Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Annals of Hematology
|
March 16, 2026
STAT6: Multidimensional analysis from hematopoietic immune regulation to pathogenesis mechanisms and therapeutic targets in hematologic malignancies
Shuni Zhang, Shuzhen Xiong, Xinyang Liu, et al.
Frontiers in Oncology
|
May 14, 2025
A potential prognostic marker for hematologic neoplasms: CD58
Jiajia Cao, Yurong Zhang, Ningning Yue, et al.
Free Radical Biology & Medicine
|
December 6, 2025
The expression and significance of CXCL13 and CXCR5 in the tumor microenvironment of primary central nervous system diffuse large B-cell lymphoma
Cuicui Li, Litian Zhang, Qiqi Jin, et al.
Leukemia & Lymphoma
|
April 29, 2026
CD47: a promising target for immunotherapy in relapsed/refractory malignant lymphoma
Shuzhen Xiong, Ningning Yue, Shuni Zhang, et al.
Analytical Chemistry
|
December 8, 2020
Tyrosine-EDC Conjugation, an Undesirable Side Effect of the EDC-Catalyzed Carboxyl Labeling Approach
Qingqing Li, Yang Zhang, Zhen Wu, et al.
Annals of Hematology
|
June 19, 2026
Venetoclax plus Idarubicin and cytarabine as frontline induction for newly diagnosed acute myeloid leukemia in young, fit adults: a real-world study
Chengcheng Ma, Ningning Yue, Wanli Hu, et al.
Virology
|
May 23, 2026
Corrigendum to "Kobuvirus VP3 protein restricts the IFN-β-triggered signaling pathway by inhibiting STAT2-IRF9 and STAT2-STAT2 complex formation" [Virology 507 (2017) 161-169]
Qianqian Peng, Xi Lan, Chen Wang, et al.
Iscience
|
April 20, 2026
Liquid-liquid phase separation in cancer therapy resistance
Peng Hu, Huaze Ding, Ningning Yue, et al.
Virology
|
April 26, 2017
Kobuvirus VP3 protein restricts the IFN-β-triggered signaling pathway by inhibiting STAT2-IRF9 and STAT2-STAT2 complex formation
Qianqian Peng, Xi Lan, Chen Wang, et al.
Leukemia & Lymphoma
|
January 10, 2024
The prognostic value of CD8<sup>+</sup> CTLs, CD163<sup>+</sup> TAMs, and PDL1 expression in the tumor microenvironment of primary central nervous system lymphoma
Qiqi Jin, Haoyun Jiang, Ningning Yue, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Annals of Hematology
|
March 16, 2026
STAT6: Multidimensional analysis from hematopoietic immune regulation to pathogenesis mechanisms and therapeutic targets in hematologic malignancies
Shuni Zhang, Shuzhen Xiong, Xinyang Liu, et al.
Frontiers in Oncology
|
May 14, 2025
A potential prognostic marker for hematologic neoplasms: CD58
Jiajia Cao, Yurong Zhang, Ningning Yue, et al.
Free Radical Biology & Medicine
|
December 6, 2025
The expression and significance of CXCL13 and CXCR5 in the tumor microenvironment of primary central nervous system diffuse large B-cell lymphoma
Cuicui Li, Litian Zhang, Qiqi Jin, et al.
Leukemia & Lymphoma
|
April 29, 2026
CD47: a promising target for immunotherapy in relapsed/refractory malignant lymphoma
Shuzhen Xiong, Ningning Yue, Shuni Zhang, et al.
Analytical Chemistry
|
December 8, 2020
Tyrosine-EDC Conjugation, an Undesirable Side Effect of the EDC-Catalyzed Carboxyl Labeling Approach
Qingqing Li, Yang Zhang, Zhen Wu, et al.
Annals of Hematology
|
June 19, 2026
Venetoclax plus Idarubicin and cytarabine as frontline induction for newly diagnosed acute myeloid leukemia in young, fit adults: a real-world study
Chengcheng Ma, Ningning Yue, Wanli Hu, et al.
Virology
|
May 23, 2026
Corrigendum to "Kobuvirus VP3 protein restricts the IFN-β-triggered signaling pathway by inhibiting STAT2-IRF9 and STAT2-STAT2 complex formation" [Virology 507 (2017) 161-169]
Qianqian Peng, Xi Lan, Chen Wang, et al.
Iscience
|
April 20, 2026
Liquid-liquid phase separation in cancer therapy resistance
Peng Hu, Huaze Ding, Ningning Yue, et al.
Virology
|
April 26, 2017
Kobuvirus VP3 protein restricts the IFN-β-triggered signaling pathway by inhibiting STAT2-IRF9 and STAT2-STAT2 complex formation
Qianqian Peng, Xi Lan, Chen Wang, et al.
Leukemia & Lymphoma
|
January 10, 2024
The prognostic value of CD8<sup>+</sup> CTLs, CD163<sup>+</sup> TAMs, and PDL1 expression in the tumor microenvironment of primary central nervous system lymphoma
Qiqi Jin, Haoyun Jiang, Ningning Yue, et al.
Page
of 3